http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Cover -- Title Page -- Copyright -- Contents -- Abbreviations -- Chapter 1 Directed Evolution of Enzymes Driving Innovation in API Manufacturing at GSK -- 1.1 Introduction -- 1.2 Drug Development Stages -- 1.3 Enzyme Panels -- 1.4 Enzyme Engineering -- 1.5 Case Studies -- 1.6 Outlook -- Chapter 2 Survey of Current Commercial Enzyme and Bioprocess Service Providers -- 2.1 Commercial Enzyme Suppliers/Distributors -- 2.2 Bioprocess Service Providers -- 2.3 Chemical Transformations of Selected Commercially Available Enzymes -- Chapter 3 Imine Reductases
3.1 Imine Reductase-Catalysed Enantioselective Reductive Amination for the Preparation of a Key Intermediate to Lysine-Specific Histone Demethylase 1 (LSD1) Inhibitor GSK2879552 -- 3.2 Expanding the Collection of Imine Reductases Towards a Stereoselective Reductive Amination -- 3.3 Asymmetric Synthesis of the Key Intermediate of Dextromethorphan Catalysed by an Imine Reductase -- 3.4 Identification of Imine Reductases for Asymmetric Synthesis of 1-Aryl-tetrahydroisoquinolines -- 3.5 Preparation of Imine Reductases at 15 L Scale and Their Application in Asymmetric Piperazine Synthesis
5.4 Convenient Approach to the Biosynthesis of C2,C6-Disubstituted Purine Nucleosides Using E. coli Purine Nucleoside Phosphorylase and Arsenolysis -- 5.5 Production of L- and D-Phenylalanine Analogues Using Tailored Phenylalanine Ammonia-Lyases -- 5.6 Asymmetric Reductive Amination of Ketones Catalysed by Amine Dehydrogenases -- 5.7 Utilisation of Adenylating Enzymes for the Formation of N-Acyl Amides -- Chapter 6 Carbon-Carbon Bond Formation or Cleavage -- 6.1 An Improved Enzymatic Method for the Synthesis of (R)-Phenylacetyl Carbinol
Includes bibliographical references and index.